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A K-12 strain of Escherichia coli that overproduces methylenetetrahydrofolate reductase (MetF) has been
constructed, and the enzyme has been purified to apparent homogeneity. A plasmid specifying MetF with six
histidine residues added to the C terminus has been used to purify histidine-tagged MetF to homogeneity in
a single step by affinity chromatography on nickel-agarose, yielding a preparation with specific activity
comparable to that of the unmodified enzyme. The native protein comprises four identical 33-kDa subunits,
each of which contains a molecule of noncovalently bound flavin adenine dinucleotide (FAD). No additional
cofactors or metals have been detected. The purified enzyme catalyzes the reduction of methylenetetrahydrofolate to methyltetrahydrofolate, using NADH as the reductant. Kinetic parameters have been determined at
15°C and pH 7.2 in a stopped-flow spectrophotometer; the Km for NADH is 13 mM, the Km for CH2-H4folate
is 0.8 mM, and the turnover number under Vmax conditions estimated for the reaction is 1,800 mol of NADH
oxidized min21 (mol of enzyme-bound FAD)21. NADPH also serves as a reductant, but exhibits a much higher
Km. MetF also catalyzes the oxidation of methyltetrahydrofolate to methylenetetrahydrofolate in the presence
of menadione, which serves as an electron acceptor. The properties of MetF from E. coli differ from those of
the ferredoxin-dependent methylenetetrahydrofolate reductase isolated from the homoacetogen Clostridium
formicoaceticum and more closely resemble those of the NADH-dependent enzyme from Peptostreptococcus
productus and the NADPH-dependent enzymes from eukaryotes.
In Escherichia coli, methylenetetrahydrofolate reductase
(MetF) catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This reaction commits tetrahydrofolate-bound one-carbon units to use in the methylation of homocysteine to form methionine, the terminal step in
methionine biosynthesis. Hatch et al. (14) first identified the
enzyme activity in crude extracts of E. coli. NADH was shown
to be more effective than NADPH as the source of reducing
equivalents in relatively crude preparations (4). During purification of methylenetetrahydrofolate reductase from cell extracts, the ability of the enzyme to be reduced by NADH was
lost, necessitating assay of the enzyme in the presence of
NADH, an NADH-flavine adenine dinucleotide (FAD) oxidoreductase, and FAD (17). Thus, it was believed that catalysis
of the overall reaction shown in equation 1 required two enzymes: a methylenetetrahydrofolate reductase that catalyzed
transfer of reducing equivalents from reduced FAD to CH2H4folate, and an NADH-FAD oxidoreductase that catalyzed
transfer of reducing equivalents from NADH to FAD.
NADH 1 CH2-H4folate 3 NAD1 1 CH3-H4folate

purified from porcine liver (7) and has been shown to contain
noncovalently bound FAD and to use NADPH as a reductant.
By using peptide sequences from the porcine enzyme to design
oligomers, a clone for the human MTHFR gene was identified
and sequenced, and the catalytic domain of the human enzyme
was shown to exhibit extensive sequence similarity with MetF
from E. coli (12). While two other bacterial methylenetetrahydrofolate reductases have been purified and characterized,
their sequences have not been reported and they appear to
differ appreciably from the human and E. coli enzymes. The
enzyme from Clostridium formicoaceticum (5) is an iron-sulfur
flavoprotein that catalyzes reduction of CH2-H4folate with reduced ferredoxin as an electron donor. Methylenetetrahydrofolate reductase from Peptostreptococcus productus more
closely resembles the porcine and E. coli enzymes in that it
lacks iron and catalyzes the reduction of methylenetetrahydrofolate with NADH as the electron donor (34). However, this
enzyme appears to be associated with the cell membrane, in
contrast to the E. coli and mammalian enzymes.
In this paper, we report the construction of E. coli strains for
overproduction of methylenetetrahydrofolate reductase and
the purification and characterization of the enzyme. The E. coli
enzyme serves as a useful model for the human enzyme, mutations of which have been implicated in hyperhomocysteinemia in humans and in risk for the development of cardiovascular disease (10, 16) and neural tube defects (29). In work to
be reported elsewhere, the X-ray structure of MetF from E.
coli has been determined (13), and its availability will permit
comparison with F420-dependent enzymes with similar functions in archaebacteria (22, 31). The ease of genetic manipulation of the E. coli metF gene will also permit further studies
to define the functional properties of this important enzyme.
We have purified the MetF protein to homogeneity and

(1)

The metF gene specifies methylenetetrahydrofolate reductase.
This gene is located in the metJBLF gene cluster, which was
cloned and mapped by Zakin et al. (35). The metF gene was
sequenced, and the gene product was shown to be a polypeptide of 33 kDa (24). However, we are unaware of publications
reporting further characterization of the E. coli enzyme.
Methylenetetrahydrofolate reductase has previously been
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shown it to be a flavoprotein capable of catalyzing the NADHlinked reduction of CH2-H4folate to CH3-H4folate without
added enzymes or cofactors. The purified enzyme is a tetramer, but when diluted it readily loses its FAD cofactor,
possibly accounting for the loss of catalytic function during
earlier attempts at purification.
MATERIALS AND METHODS
Reagents. Restriction enzymes and DNA-modifying enzymes were obtained
from Promega, New England BioLabs, or Boehringer Mannheim. Taq polymerase and buffer were obtained from Boehringer Mannheim. Vent polymerase and
buffer were purchased from New England BioLabs. Nonradioactive (6R,S)CH3H4folate and H4folate were obtained from B. Schircks, Jona, Switzerland.
NADH, menadione, FAD, and dimedone were purchased from Sigma. (6R,S)
[methyl-14C]CH3-H4folate was purchased from Amersham Life Sciences as the
barium salt. Luria broth was prepared as previously described (25). Formaldehyde, formic acid, hydrochloric acid, methanol, ascorbic acid, acrylamide, ampicillin, riboflavin, IPTG (isopropyl-b-D-thiogalactopyranoside), EDTA, phosphate, sodium chloride, glycerol, bovine serum albumin, nickel sulfate,
imidazole, phosphate, NaCl, glycerol, and agarose were supplied by various
commercial sources and were used without further purification. HiTrap chelating
columns were obtained from Pharmacia, Piscataway, N.J. The DNA primers
used for isolation of the metF gene were synthesized at the University of Michigan DNA Synthesis Core Facility.
Assays. (i) CH3-H4folate-menadione oxidoreductase assay. In the presence of
a high potential electron acceptor like menadione, methylenetetrahydrofolate
reductase oxidizes [methyl-14C]CH3-H4folate to 14CH2O (formaldehyde) and
H4folate (8, 19). Radiolabeled formaldehyde was complexed with dimedone and
extracted with toluene. Formation of the formaldehyde product was measured by
scintillation counting.
The 800-ml reaction mixture contained 60 ml of the radiolabeled (6R,S)[methyl-14C]CH3-H4folate cocktail (4.17 mM, 1,200 dpm/nmol), 100 ml of 1 M phosphate buffer (pH 6.3), 60 ml of 0.5 mM FAD, 200 ml of menadione stock, and 100
ml of 2% bovine serum albumin in 30 mM EDTA. This mixture was preincubated
at 37°C for 5 min, and then enzyme was added to initiate the reaction. After 30 s,
the assay was terminated by the addition of 300 ml of dimedone and heat
treatment at 98°C for 2 min. The reaction mixtures were cooled on ice for 2 min,
and 3 ml of toluene was added. The mixture was vortexed and spun in a clinical
centrifuge at 4,000 rpm for 5 min. A 1-ml volume of the toluene phase was added
to 10 ml of Eco-lite scintillation cocktail (ICN Biomedicals Inc.) and counted in
a Beckman scintillation counter. Units for this assay are defined as micromoles
of formaldehyde formed per minute.
The radioactive methyltetrahydrofolate cocktail for this assay was prepared by
adding 50 mCi of 5-[14C](6R,S)methyltetrahydrofolic acid (specific activity, 54
mCi/mmol) to 5 ml of 8 mM ascorbic acid and combining the mixture with 19 ml
of ascorbate buffer containing 60.1 mg of unlabeled (6R,S)CH3-H4folate. A
menadione stock solution was prepared by diluting 1 volume of a saturated
solution of menadione in methanol with 4 volumes of water. The precipitate that
formed was removed by filtering. The solution was stirred in the dark for 10 min
and then refiltered and stored in the dark. The concentration of menadione in
this stock solution was found to be 1.4 mM by measuring A340 and using a molar
absorbance coefficient of 3,100 M21 cm21 (30).
(ii) NAD(P)H-menadione oxidoreductase assay. The NAD(P)H-menadione
oxidoreductase activity was measured at 25°C, using the method of Donaldson
and Keresztesy (8) as modified by Matthews (19). In a total volume of 3 ml, the
reaction mixture consisted of 1.5 ml of 100 mM potassium phosphate buffer (pH
7.2) with 0.6 mM EDTA, 300 ml of menadione stock (prepared as described
above), and 125 mM NADH. The mixture was incubated at 25°C for 5 min, and
then enzyme was added to initiate the reaction. Activity was monitored as a
decrease in the absorbance of NADH at 343 nm, where menadione and menadiol are isosbestic. Activities are presented as the initial rate of NADH oxidation
observed, using an extinction coefficient of 6,220 M21 cm21 for NADH at 343
nm. Activity units represent micromoles of NADH oxidized per minute.
(iii) NADH-CH2-H4folate oxidoreductase assay. In the NADH-CH2-H4folate
oxidoreductase assay, MetF oxidizes NADH and reduces CH2-H4folate to CH3H4folate. The assay is a modification of the NADPH-CH2-H4folate oxidoreductase assay originated by Kutzbach and Stokstad (18) and described by Matthews
(19). In our modification, the assay was performed in a stopped-flow spectrophotometer at 15°C. MetF (20 mM in enzyme-bound flavin) was mixed with an
equal volume of buffer containing NADH and CH2-H4folate. Cycles of alternating vacuum and argon gas flow over the samples prior to mixing were used to
deaerate both solutions.
To determine the Km and KiA for NADH, deaerated 20 mM enzyme was mixed
anaerobically with deaerated solutions containing 60 mM (6R)CH2-H4folate and
concentrations of NADH varying from 10 to 400 mM. Enzyme activity was
measured as a decrease in the FAD absorbance of the enzyme by monitoring the
enzyme absorbance at 447 nm. The buffer for both the enzyme and substrate
solutions was 50 mM potassium phosphate (pH 7.2) (KPi) buffer containing 10%
glycerol and 0.3 mM EDTA. The CH2-H4folate was added as a 6R,S mixture and
was prepared anaerobically by adding 5 ml deaerated 50 mM KPi buffer, con-
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taining 10% glycerol and 0.3 mM EDTA, to 27.7 mg of H4folate under nitrogen.
Reagent formaldehyde (81 ml of a 14.26 M stock) was added to generate 10 mM
(6R,S)CH2-H4folate.
The Km and KiB for CH2-H4folate were also determined by the NADH CH2H4folate oxidoreductase assay. Deaerated 20 mM enzyme was mixed anaerobically with deaerated solutions containing 200 mM NADH and concentrations of
(6R)CH2-H4folate varying from 30 to 2,000 mM. The oxidation of NADH was
observed as a decrease in the absorbance at 340 nm.
Subcloning of metF. Plasmid pEJ3-1B contains the metF gene, including the 59
upstream region regulated by an S-adenosylmethionine (AdoMet)-MetJ complex, half of Tn5 including the gene coding for neomycin phosphotransferase,
and 1.5 kb of additional bacterial DNA 39 to E. coli metF (9). To overproduce the
desired protein, extraneous material from the pEJ3-1B clone was removed and
the coding region of metF was subcloned into the EcoRI site of plasmid pTrc99A
(Pharmacia) to generate the overexpression plasmid pCAS-5. The metF coding
region in pEJ3-1B was amplified by PCR using pEJ3-1B as a template and
primers 144C and 145C*, where the asterisk denotes a sequence corresponding
to the reverse complement of the sense strand. Primers 144C (59-ggaactgcagAT
TGATGAGGTAAGGTATGA--39) and 145C* (59-ggaagacgtcTTATAAACCA
GGTCGAACCCC-39) were generated to anneal to the 59 and 39 ends, respectively, of the E. coli metF coding sequence. The primers were designed to include
the metF ribosome binding site, GAGG, the ATG translation initiation codon at
the 59 end of the gene, and a sequence complementary to the TAA stop codon,
TTA, at the 39 end of the gene. In addition, primers 144C and 145C* contain 10
bp of DNA sequence (lowercase) that are not contained within the metF gene
but appear in the final construct at the 59 and 39 ends of the metF gene.
The 927-bp PCR product was composed of 888 bp comprising the coding
region of metF, the 3-bp termination codon, 16 bp of 59 untranslated region that
contained the ribosome binding site, and 20 bp introduced by the primers that
were not part of metF. Ligation of the PCR product into the Invitrogen TA
cloning vector pCRII generated plasmid pCAS-3. This plasmid was then digested
with the restriction enzyme EcoRI to generate a 943-bp fragment. The EcoRI
site was contained within plasmid pCRII, adding 16 bp from this plasmid to the
927-bp PCR fragment containing the metF gene. This 943-bp fragment was
ligated into the EcoRI site of dephosphorylated expression vector pTrc99A
(Pharmacia) to generate plasmid pCAS-5.
Purification of wild-type MetF. E. coli AB1909 (metF arg lac), which contains
a mutation in metF that leads to methionine auxotrophy (32), was transformed
with pCAS-5 to generate the overexpression strain CAS-9. Cells of strain CAS-9
were inoculated in LB to an optical density at 420 nm (OD420) of 0.05, grown
aerobically in a rotary action shaker at 37°C to an OD420 of 1.0, and then induced
with 0.5 mM isopropyl-b-D-thiogalactopyranoside (IPTG) and allowed to continue growing for 3 h. The cells were pelleted and resuspended in 50 mM KPi
buffer (pH 7.2) containing 10% glycerol and 0.3 mM EDTA. The protease
inhibitors phenylmethylsulfonyl fluoride and tosyl-L-lysine chloromethylketone
were added to final concentrations of 50 mM and 100 mM, respectively, prior to
sonication. The cells were sonicated with a Branson sonifier at a setting of 8. To
prevent overheating, seven 1-min sonication cycles were alternated with 2-min
recovery periods. The sonicate was centrifuged at 35,000 3 g for 1 h at 4°C, and
the supernatant was collected.
Purification of MetF to homogeneity required a three-column purification
process involving anion-exchange and hydrophobic interaction chromatography.
It is similar to the procedure developed by Wohlfarth et al. (34) for the purification of methylenetetrahydrofolate reductase from P. productus. DEAE fastflow Sepharose resin was used for the first separation. The sonicate supernatant
was applied to a 2- by 50-cm DEAE column equilibrated with 50 mM KPi
containing 10% glycerol and 0.3 mM EDTA. The column was washed with 50
mM KPi–10% glycerol–0.3 mM EDTA and eluted with a linear gradient from 50
to 500 mM KPi. The fraction containing MetF can be identified by absorbance at
447 nm; if sufficient enzyme is present, MetF can be visually identified by its
intense yellow color. As this step is a bulk purification to remove DNA, RNA,
and cellular debris, the yellow fractions were combined without regard to enzyme
purity. For buffer exchange of the pooled protein fractions, an Amicon apparatus
with a YM100 membrane was used. Care was taken to prevent dilution of the
protein below 100 mM, which results in FAD dissociation and protein precipitation. Concentrating the protein solution and then adding buffer to restore the
volume prior to concentration accomplished buffer exchange. The procedure was
repeated until the protein was in 50 mM KPi (pH 7.2) with 10% glycerol and 0.3
mM EDTA.
The second purification step used fast protein liquid chromatography (FPLC)
with a Pharmacia Mono Q anion-exchange resin. A Mono Q HR 16/10 column
(20-ml bed volume) was used, and MetF was eluted with a salt gradient from 50
to 375 mM KPi with 10% glycerol and 0.3 mM EDTA. MetF elutes at approximately 300 mM KPi. The cleanest fractions, as determined by electrophoresis on
sodium dodecyl sulfate (SDS)-polyacrylamide gels, were combined, and 1 volume of 1.6 M (NH4)2SO4 was added so that the final buffer composition of the
protein was approximately 0.8 M (NH4)2SO4–100 mM KPi (pH 7.2) with 5%
glycerol and 0.15 mM EDTA. For the third purification step, the protein was
then loaded onto a 2- by 10-cm Phenyl-sepharose HP FPLC column (Pharmacia)
preequilibrated with 0.8 M (NH4)2SO4 in 100 mM KPi (pH 7.2) containing 10%
glycerol and 0.3 mM EDTA. A reverse gradient from 0.8 to 0.0 M (NH4)2SO4 in
the same buffer was used to elute the enzyme. Pure E. coli MetF eluted at the
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very end of the gradient. The protein was exchanged into 50 mM KPi (pH 7.2)
with 10% glycerol and 0.3 mM EDTA by size exclusion chromatography and
stored at 280°C at a minimum concentration of 150 mM to ensure long-term
protein stability.
Protein concentration determinations. Protein determinations were performed by a Coomassie blue dye-binding method (3) implemented via the BioRad protein assay (Hercules, Calif.) and were compared with standard curves
obtained with bovine serum albumin. Determination of the protein concentration of purified MetF by amino acid analysis gave a value 65.2% of that obtained
by the Bio-Rad protein assay. Therefore, a factor of 0.652 was used to correct
values obtained by the Bio-Rad protein assay for samples of enzyme with specific
activities of .2.4 mmol min21 mg21 in the CH3-H4folate-menadione oxidoreductase assay. Enzyme concentrations were routinely determined from the
visible absorbance at 447 nm due to bound FAD, using a molar absorbance
coefficient of 14,300 M21 cm21 (see Results).
Amino acid analysis. Analyses were performed at the University of Michigan
Protein and Carbohydrate Core Facility, using an Applied Biosystems model
420H automated amino acid analyzer, with precolumn derivatization of the
protein hydrolysate with phenylisothiocyanate.
Construction of a strain producing histidine-tagged MetF. The PCR-based
primer overlap extension method (15) was used to produce a plasmid for production of histidine-tagged MetF. Generation of the histidine-tagged version of
MetF required the removal of the stop codon from the metF gene and insertion
of the coding sequence for the gene into the pET-23b vector (Novagen, Milwaukee, Wis.), which contains six histidine codons and a termination codon downstream of and in frame with a 6-bp XhoI site. Primers 144C (see above), 3311E*
(59-cccagtgctgcaatgataccg-39), 3312E* (59-gcttgcatgcctgcactcGAGTAAACCAG
GTCGAAC-39), and 3313E (59-GTTCGACCTGGTTTACTCgagtgcaggcatgcaa
gc-39) were used to generate plasmid pCAS-28 containing the wild-type coding
sequence with the original stop codon removed. The asterisks indicate sequences
corresponding to the reverse complement of the sense strand. Sequences contained within the coding sequence are shown in uppercase, while those from
flanking regions are shown in lowercase; underlined sequences indicate changes
made to introduce an XhoI site in place of the original stop codon. Separate
amplification reactions were performed with the wild-type expression plasmid
pCAS-5 as the DNA template and either 144C and 3312E* or 3313E and 3311E*
as primers. The two amplified DNA fragments were then combined and amplified by using 144C and 3311E* as primers. The resultant 2,245-bp PCR product
was digested with BglI and BspEI to generate a 1,696-bp fragment, containing the
entire E. coli metF gene with a XhoI site instead of a stop codon at the 39 end of
the gene. This fragment was reintroduced between the BglI and BspEI sites in
pCAS-5, replacing the original metF sequence with one that contained an XhoI
restriction site at the carboxy terminus and no stop codon. The resultant plasmid,
pCAS-28, was digested with XbaI and XhoI to generate a 922-bp fragment
containing the full-length mutated gene. Plasmid pET-23b was digested with
XbaI and XhoI, which removed a 117-bp fragment from the plasmid that specifies
an unwanted amino-terminal T7 tag fusion protein, the vector-encoded ribosome
binding site, and part of the multicloning region. The 922-bp XbaI-XhoI gene
fragment was ligated into the 3,547-bp XbaI-XhoI fragment of pET-23b to generate the expression vector pCAS-30. This plasmid contains the metF coding
sequence juxtaposed to a C-terminal histidine tag. The resulting construct specifies a protein that contains two mutated residues (Leu-Glu) at the C terminus of
the original sequence, introduced by formation of the XhoI site, followed by six
histidine residues.
Production of histidine-tagged MetF. The histidine-tagged protein was produced by using E. coli EET01, which contains plasmid pCAS-30 in a
BL21(DE3)recD1 (Novagen) background. Use of the BL21(DE3)recD strain
results in substantially lower levels of accumulation. The BL21(DE3) background contains a chromosomal copy of the T7 RNA polymerase under control
of the lacUV5 promoter. T7 RNA polymerase was required for production of the
histidine-tagged proteins. Although polymerase production is induced by IPTG
in this strain, we did not observe increased accumulation of MetF on addition of
IPTG, and IPTG was not added to any of our cultures.
One liter of Luria broth, supplemented with ampicillin (100 mg/ml) and riboflavin (10 mM), was inoculated to an OD600 of 0.015 with strain EET01. The cells
were allowed to grow in a rotary action shaker at 37°C until they reached
stationary phase (OD600 of ;5), after approximately 9 h. The cells were pelleted
at 11,000 3 g for 10 min, and the supernatant was removed.
Purification of histidine-tagged methylenetetrahydrofolate reductase. Pelleted
cells producing histidine-tagged MetF were resuspended by adding 50 ml of
ice-cold buffer (10 mM imidazole in 20 mM phosphate buffer [pH 7.4] containing
500 mM NaCl) per ml of cell culture. The cell suspensions were then sonicated
in the presence of the protease inhibitors phenylmethylsulfonyl fluoride and
tosyl-L-lysine chloromethyl ketone as described above. The supernatant was
separated from cell debris by centrifugation at 35,000 3 g for 1 h at 4°C.
Purification of the histidine-tagged protein was accomplished by using a nickel
affinity column. The nickel column was generated by charging the HiTrap chelating column (Pharmacia) with Ni21, using nickel sulfate. Using a peristaltic P-1
pump (Pharmacia), the sonicate supernatant was loaded onto a 5-ml nickel
column previously equilibrated with 50 ml of 10 mM imidazole in 20 mM
phosphate (pH 7.4) with 500 mM NaCl. The histidine-tagged protein bound to
the nickel column along with some nonspecifically bound protein. Nonspecifi-
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cally bound proteins were eluted by washing with 50 ml of loading buffer followed
by 50 ml of the same buffer containing 100 mM imidazole. Homogeneous histidine-tagged E. coli MetF was then eluted with the same buffer containing 300
mM imidazole. Fractions (400 ml) were collected, and glycerol was added to 10%
(wt/vol). Approximately 4 mg of protein from each fraction was run on an
SDS-polyacrylamide gel to identify pure fractions. The pure fractions were
pooled, and the buffer was exchanged to 50 mM KPi, (pH 7.2) with 10% glycerol
and 0.3 mM EDTA, using size exclusion chromatography on an FPLC Superose-12 column. The protein was stored at 280°C at a concentration of .100 mM.
Determination of the molar absorbance of enzyme-bound FAD. Enzymebound flavin was released by denaturing the enzyme by addition of an equal
volume of 7.5 M guanidine HCl in 1 M Tris-HCl at pH 7.2. The absorbance of
the liberated FAD was compared to the absorbance of a known quantity of free
FAD. The molar absorbance coefficient of FAD in aqueous solution at neutral
pH is 11,300 M21 cm21 at 450 nm (1); the molar absorbance increases 4.85% on
dilution with guanidine hydrochloride (6), yielding a molar absorbance coefficient of 11,850 M21 cm21.
Apparent mass of the native enzyme. The oligomeric state of the MetF protein
was determined by size exclusion chromatography using an FPLC Superose-12
HR 10/30 gel filtration column (Pharmacia). Concentrated protein was diluted to
61 mM in 50 mM KPi buffer (pH 7.2) with 10% glycerol and 0.3 mM EDTA. The
protein was applied to the column and eluted with 50 mM KPi (pH 7.2) with 10%
glycerol and 0.3 mM EDTA at 0.5 ml/min. The migration and elution of the
protein peak was ascertained by continuous monitoring of the column eluant at
276 nm. The elution volume of the protein was compared to the elution volumes
of gel filtration protein standards (Bio-Rad) dissolved in the same buffer. The
elution volumes of the standards were used to generate a calibration curve for
the column, and the native molecular weight for the MetF samples was calculated using this calibration curve. The subunit molecular weight of histidinetagged MetF was determined by electrospray mass spectrometry at the University of Michigan Protein and Carbohydrate Core Facility.

RESULTS
Subcloning of metF and construction of an overproducing
strain. Plasmid pEJ3-1B, containing the E. coli metF gene
specifying methylenetetrahydrofolate reductase, was obtained
as a generous gift from James Johnson (9). This plasmid also
contains the 59 upstream region regulated by an AdoMet-MetJ
complex, half of Tn5 including the gene coding for neomycin
phosphotransferase, and 1.5 kb of additional bacterial DNA 39
of E. coli metF. To overproduce MetF, it was desirable to
remove the regulatory region, so that cells could be grown in
LB medium without down-regulation of metF expression. Extraneous material from the pEJ3-1B clone was removed as
described in Materials and Methods, and the coding region of
metF was subcloned into pTrc99A to generate the overexpression plasmid pCAS-5. This plasmid contains a 943-bp DNA
fragment of which 907 are bp 4151 to 5057 of metF (numbered
according to GenBank accession no. AE000468) cloned into
the EcoRI site of pTrc99A. Plasmid pCAS-5 was introduced
into E. coli AB1909 (metF) to create strain CAS-9. Following
growth in LB containing IPTG, approximately 20% of the total
cellular protein is E. coli MetF. Thus, removing the regulatory
region and placing protein production under the control of the
trc promoter leads to high levels of MetF accumulation.
Purification of MetF to homogeneity. Wild-type E. coli MetF
enzyme was produced from strain CAS-9 as described in Materials and Methods. Purification of MetF to homogeneity requires a three-column purification process involving anionexchange and hydrophobic interaction chromatography (see
Materials and Methods for details). Table 1 summarizes the
purification and reports specific activities measured with the
CH3-H4folate-menadione oxidoreductase assay. Precautions
are taken such that the enzyme is not diluted to below 100 mM
to eliminate dilution-related inactivation of the protein. In
particular, size exclusion chromatography was used for buffer
exchange prior to storage of homogeneous enzyme. The protein was stored at 280°C in a solution of 50 mM KPi (pH 7.2)
with 10% glycerol and 0.3 mM EDTA at a minimum concentration of 150 mM to ensure long-term protein stability. Protein

CHARACTERIZATION OF MetF FROM E. COLI

VOL. 181, 1999
TABLE 1. Purification of wild-type MetF from E. colia
Purification step

Vol
(ml)

TABLE 2. Purification of histidine-tagged MetF from E. colia

Total
Fold
Sp act
Proteinb
Yield
activityc
purifi(mg)
(U/mg)
(%)
(U)
cation

Sonication supernatant 107
324
after centrifugation
DEAE-Sepharose
24
159
chromatography
FPLC on Mono Q
7.0 12.2d
resin
Chromatography on
9.3
4.0d
phenyl-Sepharose
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194

0.60

1.0

100

177

1.11

1.9

91

43

3.52

5.9

22

18.7

4.67

7.8

9.6

a

Yields are reported for 1 liter of cultured cells.
Determined by the Bio-Rad protein assay (3).
Determined by using the CH3-H4folate-menadione oxidoreductase assay and
5-min incubations. We subsequently realized that the assay was not linear for 5
min, and activity values have been multiplied by 4.79, which is the ratio of activity
measured in 30-s versus 5-min assays. Units are micromoles of CH3-H4folate
oxidized per minute at 37°C.
d
Protein concentration measured by the Bio-Rad protein assay was corrected
by using a correction factor of 0.652 (see Materials and Methods).
b
c

is stable at this concentration for up to a year, provided that it
does not undergo repeated freezing and thawing.
Properties of purified methylenetetrahydrofolate reductase.
The wild-type MetF protein is isolated as a flavoprotein as
indicated by its yellow color. The flavin is nonfluorescent when
bound to MetF apoenzyme but becomes fluorescent when released from the protein, e.g., by thermal denaturation. Since
FAD is much less fluorescent than flavin mononucleotide
(FMN), the two forms of flavin can be distinguished by treatment of the released flavin with snake venom phosphodiesterase, which converts FAD to FMN with an accompanying 10fold increase in fluorescence (2). In this manner, the flavin
bound to MetF was shown to be FAD, as suggested from
earlier studies (14, 17). The molar absorbance of MetF was
determined by comparing the absorbances of the enzyme before and after the release of FAD. FAD was released by denaturing the enzyme with guanidine hydrochloride and comparison of the absorbance of the liberated FAD with that of a
known quantity of free FAD (1). The molar extinction coefficient was determined to be 14,300 M21 cm21 for the enzymebound FAD. The enzyme concentration that was determined
from the absorbance at 447 nm due to enzyme-bound FAD was
1.06 times the subunit concentration determined by amino acid
analysis, indicating that within experimental error, the enzyme
is isolated with one equivalent of FAD bound per subunit.
The enzyme was found to lose activity upon dilution. As is
evident from the data in Table 1, significant losses were observed during purification, especially during chromatographic
procedures that resulted in dilution of the enzyme. We therefore decided to construct a modified MetF with a histidine tag
at the C terminus, so that the protein could be purified by
chromatography on nickel agarose. Strain BL21(DE3) was
transformed with pCAS-30 (see Materials and Methods) and
used to produce the histidine-tagged MetF protein. A summary of the purification is shown in Table 2. The protein could
be purified to homogeneity in a single step with 96% yield. The
specific activity of the purified protein (5.37 U/mg) is comparable to that of the wild-type protein (4.67 U/mg), but 1 liter of
cell culture yielded 58 mg of purified MetF, compared to 4 mg
obtained per liter of cells producing wild-type MetF.
Histidine-tagged MetF protein has a predicted subunit molecular weight of 34,062, calculated assuming that the N-terminal methionine is removed. Determination of a peptide
mass of 34,072 6 10 by electrospray mass spectrometry was

Purification step

Sonication supernatant
after centrifugation
Chromatography on
nickel affinity
column

Total
Fold
Sp act
Vol Proteinb
Yield
activityc
purifi(mg)
(U/mg)
(ml)
(%)
(U)
cation

52

1,300

629

0.48

1.0

100

9

113d

607

5.37

11.0

96

a

Two liters of cultured cells was used for this preparation.
Determined by the Bio-Rad protein assay (3).
Determined by the CH3-H4folate-menadione oxidoreductase assay using 30 s
incubations. Units are micromoles of CH3-H4folate oxidized per minute at 37°C.
d
Protein concentration determined by the Bio-Rad protein assay (3) was
corrected by using a correction factor of 0.652 (see Materials and Methods).
b
c

consistent with removal of the initiator methionine residue.
The oligomeric state of the histidine-tagged MetF protein was
determined by size exclusion chromatography as described in
Materials and Methods. The elution volume of MetF is compared with those of standard proteins in Fig. 1. MetF applied
to the column at an initial concentration of 61 mM enzymebound FAD eluted at a volume equivalent to a molecular mass
of 119 6 2 kDa, or 3.5 subunits of 34 kDa per molecule,
suggesting that the protein is a tetramer. The recent determination of the structure of E. coli MetF by X-ray crystallography
confirms the tetrameric structure of the native wild-type (nonhistidine-tagged) enzyme (13).
Histidine tagging did not affect any of the enzyme properties
that we have examined. The unmodified enzyme also migrates
as a tetramer during size exclusion chromatography. Differential scanning calorimetry indicated similar melting temperatures for the wild-type (58.6°C) and histidine-tagged (58.4°C)
proteins. Thus, the introduction of additional residues at the C
terminus of the protein does not appear to have altered the
physical properties of the enzyme.

FIG. 1. Determination of the apparent molecular weight of histidine-tagged
MetF by gel filtration. The oligomeric state of MetF was determined by size
exclusion FPLC on a Superose-12 HR 10/30 gel filtration column. Concentrated
protein was diluted to 61 mM in 50 mM KPi (pH 7.2) containing 10% glycerol
and 0.3 mM EDTA, loaded on the column, and eluted with the same buffer. The
elution volume is compared with those of compounds in the Bio-Rad gel filtration standard kit. These compounds and their molecular weights are as follows
(unfilled circles, from left to right): bovine thyroglobulin, 670,000; bovine gamma
globulin, 158,000; chicken ovalbumin, 44,000; horse myoglobin, 17,000; and vitamin B12, 1,350. The results of duplicate determinations of the standard curve
are indicated. The duplicate determinations of MetF (filled circle) yielded identical elution volumes corresponding to an apparent molecular weight of 119,400.
This molecular weight is consistent with the concentrated native enzyme eluting
as a tetramer of expected Mr of 136,248 (4 3 34,062).
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FIG. 2. Overlay of oxidized and NADH-reduced MetF spectra. Purified enzyme, 22 mM in potassium phosphate buffer (pH 7.2) containing 10% glycerol
and 0.3 mM EDTA, was equilibrated with argon, and the spectrum was recorded.
The absorbance shown (solid line) has been corrected for the subsequent twofold
dilution of the enzyme and is equivalent to that of 11 mM enzyme. The enzyme
was mixed with an equal volume of 200 mM NADH in the same buffer, and the
spectrum of the reduced enzyme (dashed line) was recorded.

Catalytic properties of methylenetetrahydrofolate reductase. Figure 2 shows the absorbance spectrum of the purified
wild-type enzyme. This spectrum, with maxima at 447 and 380
nm, is characteristic of a flavoprotein. On addition of NADH,
the spectrum is converted to a featureless curve lacking discrete bands above 400 nm; this spectrum is characteristic of a
reduced flavoprotein, indicating that NADH is able to reduce
the flavin of MetF. The initial rate of reduction of MetF by
various concentrations of NADH was monitored in a stoppedflow spectrophotometer at 15°C. The results are shown in Fig.
3. A saturable hyperbolic binding curve for NADH is observed,
with an apparent Kd of 37 mM and a maximum observed rate
of 34 s21, or ;2,000 min21.
The physiological reaction catalyzed by MetF is the reduction of CH2-H4folate to form CH3-H4folate. We monitored the
physiological reaction at 15°C in a stopped-flow spectrophotometer by mixing enzyme with CH2-H4folate and NADH. The
enzyme and substrate solutions were equilibrated with argon
prior to mixing, and the reaction was conducted under rigorously anaerobic conditions. Details of the procedure are presented in Materials and Methods. Enzyme, 20 mM in bound
FAD, was mixed with an equal volume of buffer containing 60
mM (6R)CH2-H4folate and 10 to 400 mM NADH, and the
initial rate of flavin reduction was monitored at 447 nm. The
measured initial velocity is plotted against the NADH concentration. The inset to Fig. 4 shows the initial rate of NADH
oxidation measured at 340 nm when 20 mM enzyme is mixed
with an equal volume of buffer containing 200 mM NADH and
30 to 2000 mM (6R)CH2-H4folate. Marked inhibition of the
reaction is seen at high levels of CH2-H4folate, as is characteristic of enzymes that follow ping-pong kinetic mechanisms
(11). The Vmax for this reaction must be corrected for the
observed excess substrate inhibition; equation 2 has been used
to determine the Km values for NADH (A) and for CH2H4folate (B), the KiA and KiB values for substrate inhibition by
NADH and CH2-H4folate respectively, and Vmax (26) by successive iterations using Kaleidograph (Abelbeck Software,
Reading, Pa.) and comparison of the predicted curves with the
data shown in the graph and inset.
v 5

@A#@B#Vmax
KmA@B#~1 1 @B#/KiB! 1 KmB@A#~1 1 @A#/KiA! 1 @A#@B#

(2)

FIG. 3. Reaction of MetF with NADH at 15°C. Under anaerobic conditions,
20 mM oxidized enzyme in potassium phosphate buffer (pH 7.2) containing 10%
glycerol and 0.3 mM EDTA was mixed with various concentrations of NADH
dissolved in the same buffer. The reaction was monitored at 447 nm, where the
absorbance of the oxidized enzyme-bound FAD is maximal, and initial rates of
reduction were determined for each concentration. The corresponding rate constants (kobx) are plotted against the NADH concentration. The data were fit to
a hyperbolic equation (solid line) and yielded a Kd of 37 mM for NADH and a
maximal value for kobs of 34 s21.

Using this equation, Vmax/ET was calculated to be 30 6 3 s21,
KmA was 13 6 2 mM, KiA was 9 6 2 mM, KmB was 0.8 6 0.2 mM,
and KiB was 7.1 6 1.4 mM. A turnover number of 1,800 min21
can be calculated for this reaction under Vmax conditions at
15°C.
An unexpected feature of the reaction catalyzed by MetF is
that the initial rate of reduction of the enzyme-bound flavin,
which takes place during the approach to steady state, is the
same as the observed rate of NADH oxidation during the
steady state. Note that in Fig. 4, the initial rate of NADH
oxidation in the presence of 30 mM CH2-H4folate is ;160 mM

FIG. 4. Measurement of turnover in the NADH-CH2-H4folate oxidoreductase reaction at 15°C. Under anaerobic conditions in a stopped-flow spectrophotometer, enzyme, 20 mM in 50 mM potassium phosphate buffer (pH 7.2) containing 10% glycerol and 0.3 mM EDTA, was mixed with an equal volume of the
same buffer containing 30 mM (6R)CH2-H4folate and various concentrations of
NADH. The initial velocity, measured as the rate of reduction of the enzyme at
447 nm, is plotted against the NADH concentration after mixing. The inset shows
a plot of the initial velocity, measured as the rate of formation of NADH at 340
nm, determined when 20 mM enzyme was mixed with an equal volume of buffer
containing 200 mM NADH and various concentrations of CH2-H4folate [added
as a (6R,S)CH2-H4folate mixture]. Marked excess substrate inhibition is evident.
Using equation 2, the solid-line fits to the data were determined, yielding the
following values for kinetic parameters: KmA (NADH), 13 6 2 mM; KiA, 9 6 2
mM; KmB [(6R)CH2-H4folate], 0.8 6 0.2 mM; KiB, 7.1 6 1.4 mM; and Vmax/ET,
30 6 3 s21.
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s21 (v/ET is 16 s21) whether the reaction is monitored at 340
nm, where NADH absorbs (inset), or at 447 nm, where FAD
absorbs (main graph). This agreement is seen only when the
overall rate of reaction is limited by the rate of reduction of the
flavin, such that kred ,, kox as defined by equations 3 and 4
describing the reductive and oxidative half reactions:
Eox 1 NADH 3 Eox z NADHk3 Ered z NAD1 3 Ered 1 NAD1
red

(3)

Ered 1 CH2-H4folate 3 Ered z CH2-H4folatek3

ox

EoxCH3-H4folate 3 Eox 1 CH3-H4folate

(4)

In agreement with this conclusion, the turnover number, estimated to be ;1,800 min21 after correction for excess substrate
inhibition, is only slightly lower than the rate constant for
reduction of the enzyme when NADH is saturating, which is
2,000 min21 as deduced from the data in Fig. 3.
In addition to the physiological reaction, methylenetetrahydrofolate reductase also catalyzes transfer of reducing equivalents from reduced pyridine nucleotides to menadione, an artificial electron acceptor, as shown in equation 5:
NAD(P)H 1 menadione3NAD(P)1 1 menadiol

(5)

The Km for NADH was determined to be 30 mM in this assay
at 25°C, while the Km for NADPH was .300 mM under the
same conditions. Thus, NADH rather than NADPH appears
to be the physiological source of reducing equivalents for the
enzyme-bound flavin of MetF, as previously deduced from
studies with crude extracts (14).
Neither the physiological reaction nor the NADH-menadione oxidoreductase reaction is suitable for assays of crude extracts; a CH3-H4folate-menadione oxidoreductase assay is usually
used for these purposes (18, 19). When this reaction is measured
at 37°C, a Km for (6S)CH3-H4folate of 75 mM is observed, and
the turnover number under Vmax conditions is 190 min21.
Values approaching this turnover number are obtained only
with assay incubation times of 30 s, since plots of enzyme
activity versus time are linear for only 1 min.
The specific activities for the purified wild-type and histidine-tagged proteins were identical within experimental error
for the NADH-menadione oxidoreductase assay at 25°C and
the CH3-H4folate-menadione oxidoreductase assay at 37°C.
DISCUSSION
Properties of our enzyme preparations compared to those
for enzymes from other prokaryotes. Methylenetetrahydrofolate reductase from E. coli differs significantly from the enzymes with similar function previously purified from prokaryotes. The enzyme from C. formicoaceticum has been
purified to homogeneity (5). This enzyme is an a4b4 octamer
containing 26- and 35-kDa subunits. It contains 15 irons and 20
acid-labile sulfurs per octamer of 237,000, and the spectrum is
characteristic of a flavoprotein containing iron-sulfur centers.
The enzyme also contains 1.7 FAD per octamer and 2.3 zinc.
The enzyme-bound FAD is not reduced by NADH or
NADPH, but it catalyzes the reduction of CH2-H4folate with
reduced ferredoxin as an electron donor.
Wohlfarth et al. (34) have purified methylenetetrahydrofolate reductase from P. productus to homogeneity. This enzyme
is an a8 octamer of 32-kDa subunits and contains 4 FAD per
octamer. About 40% of the enzyme is recovered in the particulate fraction, suggesting that the enzyme is associated with the
cell membrane. In contrast to the clostridial enzyme, this enzyme lacks iron and catalyzes the reduction of methylenetetrahydrofolate with NADH as the electron donor. The enzyme
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TABLE 3. Comparison of properties of enzymes from E. coli
and pig liver
Property

E. coli MetF

Porcine liver
methylenetetrahydrofolate reductase

Km for CH2-H4folate (mM)
Ki for CH2-H4folate (mM)
Km for NAD(P)H (mM)
Ki for NAD(P)H (mM)
Maximum turnover in
NAD(P)H-CH2-H4folate
oxidoreductase assay (min21)

0.8 (pH 7.2)
7.1
13 (NADH)
9 (NADH)
1,800 (15°C)

88 (pH 7.2)
Not determined
16 (NADPH)
Not determined
1,700 (25°C) (19)

Km for (6S)CH3-H4folate (mM)
Maximum turnover in CH3H4folate-menadione
oxidoreductase assay (min21)

75 (pH 6.3)
190 (37°C)

25 (pH 6.7)
320 (25°C) (30)

Km for NADH (mM)
Km for NADPH (mM)
Turnover in NAD(P)Hmenadione oxidoreductase
assay (min21)
Kd for NAD(P)Ha (mM)

30 (pH 7.2)
.300
2,600 (25°C)

Not determined
28 (pH 7.2)
6,700 (25°C) (30)

37 (NADH)

28 (NADPH)

14.3

12.1

Tetramer
33,100b

Dimer
77,300c

Extinction coefficient
(mM21 cm21)
Oligomeric state
Subunit mol wt

a
Determined by measuring the rate of reduction of enzyme in a stopped-flow
spectrophotometer as a function of the concentration of reduced pyridine nucleotide.
b
Determined from the sequence of the metF open reading frame.
c
Determined by polyacrylamide gel electrophoresis in the presence of SDS
(6).

from E. coli more closely resembles the Peptostreptococcus
enzyme and eukaryotic methylenetetrahydrofolate reductases.
However, it differs from these enzymes by being an a4 tetramer
of identical subunits, each of which contains bound FAD if the
enzyme is isolated without storage at dilute concentrations.
It is difficult to compare the specific activities of the enzymes from P. productus and E. coli. The specific activity of
the P. productus enzyme in the NADH-CH2-H4folate assay
was measured at pH 5.5 and 37°C and found to be 380 mmol
min21 mg of protein21. The specific activity was reported to
decrease as the pH was raised. In contrast, the specific
activity of the E. coli enzyme in the same assay was measured at pH 7.2 and 15°C and found to be ;1 mmol min21
mg of protein21; the variation of specific activity with pH
has not yet been determined.
Comparison of properties of the enzymes from E. coli and
porcine liver. The porcine liver enzyme has been purified to
homogeneity (6) and extensively characterized. By using peptide sequences obtained from the porcine enzyme, a cDNA
specifying human methylenetetrahydrofolate reductase has
been cloned and sequenced (10, 12). Subsequently, sequences
have been obtained for putative methylenetetrahydrofolate reductase proteins from Saccharomyces cerevisiae (28), Arabidopsis thaliana (23), and Caenorhabditis elegans (33). The eukaryotic proteins are much larger (70 to 77 kDa) than the MetF
protein from E. coli, and the N-terminal halves of the proteins
show extensive sequence similarity with MetF. Limited proteolysis of the native porcine enzyme with trypsin cleaves the
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77-kDa polypeptide into an N-terminal fragment of ;40 kDa
and a C-terminal fragment of ;37 kDa. Cleavage does not affect
the activity of the enzyme but abolishes allosteric regulation of
activity by AdoMet (21). Photoaffinity labeling established that
AdoMet binds to the C-terminal 37-kDa domain (27).
The porcine enzyme is a dimer, but scanning transmission
electron microscopy of preparations of enzyme that have been
shadowed with uranyl sulfate reveals the appearance of tetrameric planar rosettes, suggesting that each subunit consists
of two separable domains (21). Sequence comparisons identify
the N-terminal domain as the catalytic domain, presumably
responsible for binding of FAD and substrates, and the Cterminal domain is thought to be involved in allosteric regulation of enzyme activity. In contrast, the bacterial enzyme is a
tetramer of identical subunits, also arranged in a planar rosette
with only one twofold axis of symmetry (13).
Table 3 compares the properties of the methylenetetrahydrofolate reductase enzymes from E. coli and porcine liver.
Both the prokaryotic and eukaryotic enzymes are capable of
transferring reducing equivalents from reduced pyridine nucleotides to either CH2-H4folate or menadione, and they can also
transfer reducing equivalents from CH3-H4folate to menadione. As mentioned above, the enzyme from E. coli uses NADH
in preference to NADPH, while the porcine enzyme uses
NADPH preferentially. However, the porcine enzyme can use
NADH as a reductant, provided that phosphate ions are
present in the assay buffer (20).
The enzyme from E. coli is markedly less stable than its
eukaryotic counterpart and readily loses its activity and flavin cofactor when present in dilute solution. In a study to be
reported elsewhere (13), we have shown that activity loss on
dilution results when the tetramer dissociates into dimers
and is associated with release of the flavin cofactor. Addition of FAD to the buffer does not completely prevent
dissociation of the tetramer into dimers when the enzyme is
dilute, although it slows the net rate of dissociation. These
properties pose difficulties both for purification and for assay and led us to construct a vector for overproduction of a
histidine-tagged MetF protein that can be purified in a single step and maintained at high concentration throughout
the purification.
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22. Nölling, J., T. D. Pihl, and J. N. Reeve. 1995. Cloning, sequencing, and
growth phase-dependent transcription of the coenzyme F420-dependent
N5,N10-methylenetetrahydromethanopterin reductase-encoding genes in two
regions of the Methanobacterium thermoautotrophicum genome. J. Bacteriol.
177:7238–7244.
23. Rounsley, S. D., S. Kaul, X. Lin, K. A. Ketchum, M. L. Crosby, R. C.
Brandon, S. M. Sykes, T. M. Mason, A. R. Kerlavage, M. D. Adams, C. R.
Somerville, and J. C. Venter. 1998. Arabidopsis thaliana chromosome II BAC
F6E13 genomic sequence. GenBank accession no. AC004005.
24. Saint-Girons, I., N. Duchange, M. M. Zakin, I. Park, D. Margarita, P.
Ferrara, and G. N. Cohen. 1983. Nucleotide sequence of metF, the E. coli
structural gene for 5,10-methylenetetrahydrofolate reductase and of its control region. Nucleic Acids Res. 11:6723–6732.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
26. Segel, I. 1975. Enzyme kinetics. Wiley-Interscience, New York, N.Y.
27. Sumner, J., D. A. Jencks, S. Khani, and R. G. Matthews. 1986. Photoaffinity
labeling of methylenetetrahydrofolate reductase with 8-azido-S-adenosylmethionine. J. Biol. Chem. 261:7697–7700.
28. Tizon, B., M. Rodriguez-Torres, E. Rodriguez-Belmonte, J. L. Cadahia, and
E. Cerdan. 1996. Identification of a putative methylenetetrahydrofolate reductase by sequence analysis of a 6.8 kb DNA fragment of yeast chromosome
VII. Yeast 12:1047–1051.
29. van der Put, N. M. J., T. K. A. B. Eskes, and H. J. Blom. 1997. Is the common
677C3T mutation in the methylenetetrahydrofolate reductase gene a risk
factor for neural tube defects? A meta-analysis. Q. J. Med. 90:111–115.
30. Vanoni, M. A., D. P. Ballou, and R. G. Matthews. 1983. Methylenetetrahydrofolate reductase: steady state and rapid reaction studies on the NADPHmethylenetetrahydrofolate, NADPH-menadione, and methyltetrahydrofolate-menadione oxidoreductase activities of the enzyme. J. Biol. Chem. 258:
11510–11514.
31. Vaupel, M., and R. K. Thauer. 1995. Coenzyme F420-dependent N5,N10-

VOL. 181, 1999
methylenetetrahydromethanopterin reductase (Mer) from Methanobacterium thermoautotrophicum strain Marburg. Cloning, sequencing, transcriptional analysis and functional expression in Escherichia coli of the mer gene.
Eur. J. Biochem. 231:773–778.
32. Whitfield, C., E. J. Steers, and H. Weisbach. 1970. Purification and properties of 5-methyltetrahydropteroyltriglutamate-homocysteine transmethylase.
J. Biol. Chem. 245:390–401.
33. Wilson, R., R. Ainscough, K. Anderson, C. Baynes, M. Berks, J. Bonfield,
J. Burton, M. Connell, T. Copsey, J. Cooper, A. Coulson, M. Craxton, S.
Dear, Z. Du, R. Durbin, A. Favello, L. Fulton, A. Gardner, P. Green, T.
Hawkins, L. Hillier, M. Jier, L. Johnston, M. Jones, J. Kershaw, J. Kirsten,
N. Laister, P. Latreille, J. Lightning, C. Lloyd, A. McMurray, B. Mortimore,
M. O’Callaghan, J. Parsons, C. Percy, L. Rifken, A. Roopra, D. Saunders, R.

CHARACTERIZATION OF MetF FROM E. COLI

725

Shownkeen, N. Smaldon, A. Smith, E. Sonnhammer, R. Staden, J. Sulston,
J. Thierry-Mieg, K. Thomas, M. Vaudin, K. Vaughan, R. Waterston, A.
Watson, L. Weinstock, J. Wilkinson-Sproat, and P. Wohldman. 1994. 2.2 Mb
of contiguous nucleotide sequence from chromosome III of C. elegans. Nature 368:32–38.
34. Wohlfarth, G., G. Geerligs, and G. Diekert. 1990. Purification and properties
of an NADH-dependent 5,10-methylenetetrahydrofolate reductase from
Peptostreptococcus productus. Eur. J. Biochem. 192:411–417.
35. Zakin, M. M., R. C. Greene, A. Dautry-Varsat, N. Duchange, P. Ferrara,
M.-C. Py, D. Margarita, and G. M. Cohen. 1982. Construction and physical
mapping of plasmids containing the metJBLF gene cluster of E. coli K-12.
Mol. Gen. Genet. 187:101–106.

